The approval of a new drug to treat Alzheimer’s disease is controversial. The U.S. Food and Drug Administration gave full approval to the drug lecanemab (Leqembi) Thursday to treat adults with Alzheimer’s disease. In January, Public Citizen, a consumer advocacy organization, urged the agency not to approve the drug. In a letter to the FDA, […]

I’ve written about antibiotic resistance a number of times, and I have a section on it in the draft book on my journalism work. What is antibiotic resistance? Antibiotic resistance happens when germs such as bacteria and fungi develop the ability to defeat the drugs designed to kill them. That means the germs aren’t killed […]